Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mature B-cell Neoplasms × ARQ531 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 5 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, B-Cell 2 Vascular Diseases 1 Recurrence 1 Paraproteinemias 1 Neoplasms, Plasma Cell 1 Neoplasms by Histologic Type 1 Neoplasms 1 Mature B-cell Neoplasms 1 Lymphoproliferative Disorders 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Lymphatic Diseases 1 Leukemia, Lymphoid 1 Leukemia 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hemostatic Disorders 1 Hemorrhagic Disorders 1 Dendritic Cell Sarcoma, Interdigitating 1 Cardiovascular Diseases 1 Blood Protein Disorders 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05673460 2025-09-16

MK-1026-002

Merck Sharp & Dohme LLC

Phase 1 Completed

Mature B-cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡